Michael Schotsaert

9.4k total citations
71 papers, 2.2k citations indexed

About

Michael Schotsaert is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Michael Schotsaert has authored 71 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 37 papers in Immunology and 25 papers in Infectious Diseases. Recurrent topics in Michael Schotsaert's work include Influenza Virus Research Studies (35 papers), SARS-CoV-2 and COVID-19 Research (21 papers) and Respiratory viral infections research (18 papers). Michael Schotsaert is often cited by papers focused on Influenza Virus Research Studies (35 papers), SARS-CoV-2 and COVID-19 Research (21 papers) and Respiratory viral infections research (18 papers). Michael Schotsaert collaborates with scholars based in United States, Belgium and Germany. Michael Schotsaert's co-authors include Xavier Saelens, Adolfo Garcı́a-Sastre, Walter Fiers, Marina De Filette, Bert Schepens, Kenny Roose, Ashley J. Birkett, Karim El Bakkouri, Raveen Rathnasinghe and Florian Krammer and has published in prestigious journals such as Cell, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Michael Schotsaert

70 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Schotsaert United States	27	1.2k	785	698	551	259	71	2.2k
Eugene Agapov United States	27	1.2k 1.0×	1.1k 1.3×	615 0.9×	522 0.9×	174 0.7×	49	3.1k
Luis D. Giavedoni United States	30	1.1k 0.9×	1.1k 1.3×	819 1.2×	322 0.6×	95 0.4×	81	2.8k
Ali H. Ellebedy United States	27	1.5k 1.3×	1.5k 1.9×	1.8k 2.6×	1.0k 1.9×	264 1.0×	66	3.9k
Elma Tchilian United Kingdom	29	699 0.6×	1.3k 1.7×	736 1.1×	583 1.1×	110 0.4×	85	2.3k
Innocent N. Mbawuike United States	22	1.0k 0.9×	933 1.2×	300 0.4×	483 0.9×	103 0.4×	38	1.9k
Marcelle Van Mechelen Belgium	16	916 0.8×	1.6k 2.0×	440 0.6×	597 1.1×	101 0.4×	24	2.4k
Oretta Finco Italy	24	554 0.5×	1.0k 1.3×	410 0.6×	657 1.2×	206 0.8×	48	2.2k
S. M. Mansour Haeryfar Canada	27	610 0.5×	1.8k 2.3×	434 0.6×	636 1.2×	60 0.2×	90	2.9k
Irene Ramos United States	23	970 0.8×	1.0k 1.3×	339 0.5×	543 1.0×	72 0.3×	46	2.0k
Hans Henrik Gad Denmark	22	638 0.5×	1.4k 1.8×	789 1.1×	626 1.1×	38 0.1×	38	2.4k

Countries citing papers authored by Michael Schotsaert

Since Specialization

Citations

This map shows the geographic impact of Michael Schotsaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schotsaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schotsaert more than expected).

Fields of papers citing papers by Michael Schotsaert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schotsaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schotsaert. The network helps show where Michael Schotsaert may publish in the future.

Co-authorship network of co-authors of Michael Schotsaert

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schotsaert. A scholar is included among the top collaborators of Michael Schotsaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schotsaert. Michael Schotsaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

González‐Domínguez, Irene, Stephen McCroskery, Stefan Slamanig, et al.. (2025). Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models. Frontiers in Immunology. 16. 1524477–1524477. 4 indexed citations

Heide, Verena van der, Bennett Davenport, Beatrice Cubitt, et al.. (2025). Prolonged but finite antigen presentation promotes reversible defects of “helpless” memory CD8+ T cells. Immunity. 58(7). 1742–1761.e14. 1 indexed citations

Diego, Juan García-Bernalt, Pritesh Desai, Stephen T. Yeung, et al.. (2025). Helminth infections affect host immune responses to viral infections and vaccines. FEMS Microbiology Reviews. 49.

Rathnasinghe, Raveen, Lauren A. Chang, Rebecca L. Pearl, et al.. (2024). Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity. npj Vaccines. 9(1). 169–169. 4 indexed citations

Singh, Gagandeep, Juan García-Bernalt Diego, Prajakta Warang, et al.. (2024). Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice. Nature Communications. 15(1). 10178–10178. 3 indexed citations

Vincent, Richard L., David M. Rapoport, Priti Balchandani, et al.. (2024). Portable UV-C device to treat high flow of infectious aerosols generated during clinical respiratory care. Scientific Reports. 14(1). 31799–31799. 2 indexed citations

González‐Domínguez, Irene, José Luis Martínez, Stefan Slamanig, et al.. (2022). Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice. Microbiology Spectrum. 10(3). e0153822–e0153822. 18 indexed citations

Horiuchi, Shu, Wen‐Chun Liu, Nathalie Schmitt, et al.. (2021). Tox2 is required for the maintenance of GC T _FH cells and the generation of memory T _FH cells. Science Advances. 7(41). 21 indexed citations

Iwanaga, Naoki, Laura Cooper, Lijun Rong, et al.. (2021). ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2. iScience. 25(1). 103670–103670. 28 indexed citations

10.

Amanat, Fatima, Shirin Strohmeier, Raveen Rathnasinghe, et al.. (2021). Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model. mBio. 12(2). 49 indexed citations

11.

Schotsaert, Michael, Carsten Magnus, Umut Karakus, et al.. (2021). IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization. The Journal of Experimental Medicine. 218(6). 18 indexed citations

12.

Rathnasinghe, Raveen, R. F. Karlicek, Michael Schotsaert, et al.. (2021). Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device. Scientific Reports. 11(1). 19970–19970. 17 indexed citations

13.

Rathnasinghe, Raveen, Shirin Strohmeier, Fatima Amanat, et al.. (2020). Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerging Microbes & Infections. 9(1). 2433–2445. 105 indexed citations

14.

Choi, Angela, Daniel Stadlbauer, Arvind Rajabhathor, et al.. (2019). Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice. ImmunoHorizons. 3(4). 133–148. 35 indexed citations

15.

Sunwoo, Sun-Young, Michael Schotsaert, Igor Morozov, et al.. (2018). A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines. 6(3). 64–64. 16 indexed citations

16.

Yang, Ying, Paul Riccio, Michael Schotsaert, et al.. (2018). Spatial-Temporal Lineage Restrictions of Embryonic p63+ Progenitors Establish Distinct Stem Cell Pools in Adult Airways. Developmental Cell. 44(6). 752–761.e4. 133 indexed citations

17.

Hartmann, Boris, Randy A. Albrecht, Elena Zaslavsky, et al.. (2017). Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death. Nature Communications. 8(1). 1931–1931. 41 indexed citations

18.

Schotsaert, Michael, Tine Ysenbaert, Anouk Smet, et al.. (2016). Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies. Scientific Reports. 6(1). 24402–24402. 47 indexed citations

19.

Fiers, Walter, Marina De Filette, Karim El Bakkouri, et al.. (2009). M2e-based universal influenza A vaccine. Vaccine. 27(45). 6280–6283. 289 indexed citations

20.

Schotsaert, Michael, Claude Libert, Chris Vervaet, et al.. (2008). Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine. Vaccine. 27(8). 1279–1286. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact